Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants

Gepotidacin is a novel, bactericidal, first‐in‐class triazaacenaphthylene antibiotic in late‐phase development for uncomplicated urinary tract infection and uncomplicated urogenital gonorrhea. Two clinical studies were conducted to assess the pharmacokinetics (PK) and interethnic comparisons of oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Barth, Aline, Hossain, Mohammad, Perry, Caroline R., Gross, Annette S., Ogura, Hirofumi, Shabbir, Shaila, Thomas, Sebin, Dumont, Etienne F., Brimhall, Darin B., Srinivasan, Meenakshi, Swift, Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107257/
https://www.ncbi.nlm.nih.gov/pubmed/36468634
http://dx.doi.org/10.1002/cpdd.1192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107257/
https://www.ncbi.nlm.nih.gov/pubmed/36468634
http://dx.doi.org/10.1002/cpdd.1192

Ejemplares similares